Third Rock Ventures V, L.P. plan to sell securities of Rapport Therapeutics, Inc. under Form 144

Third Rock Ventures V, L.P. filed Form 144 to notify SEC of plan to sell 426005 units of Rapport Therapeutics, Inc. securities around 2026-04-17, with aggregate market value of $17,175,115.78. The total outstanding units is 47792943.0. The amount planned to be sold represents 0.89% of total outstanding units;